Business
BLDV Acquires 25% of Cann10 North America Holdings Ltd.
BLDV Acquires 25% of Cann10 North America Holdings Ltd..
About this update from Blue Diamond Ventures, Inc.
[{"type":"text","content":"\n\n Chicago, IL. /Toronto, Canada, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Blue Diamond Ventures Inc. (OTC PK: BLDV), has completed the share purchase agreements with Cann10 North America Ltd. to acquire 25% of the shares in the newly formed venture. The acquisition will make BLDV the single largest shareholder in Cann10 North America, and Josh Alper, CEO of BLDV will have one of three seats on the board of directors. $750K in BLDV restricted shares and value added services are slated for this transaction, giving Cann10 North America an initial valuation of $3MM.\n Cann10 North America Holding Ltd. is involved in the following activities: Expanding Trade and Business Activities of Cann10 to USA, Canada, Mexico, and CaribbeanOffering Medical Cannabis Education and Courses in partnership with leading Universities.Offering new Investment Opportunities in Targeted Therapies & Medical Devices.Running the industry’s premiere Medical Cannabis Industry Conferences in North America. “Cann10 North America is actively securing strategic partners” says Josh Alper, BLDV CEO. “This project touches everything we do and allows us to effectively use our network of trusted parties. Together we can provide education, access to investment in technologies and conferences all based on hard science and leading-edge research”. The acquisition completes a promise made to BLDV shareholders to set the stage for significant revenue creation in 2018, with Global Partners focused on leading-edge Cannabis Research, Production and Clinical Trials. The new company, located in Canada has already captured the attention of multiple Licensed Producers (LP’s) in the rapidly expanding Canadian Cannabis Market, and has had offers of equity positions, consulting services, and more, based on access to the Israeli pipeline of products and IP, and the strong background of the team in providing Medical Education in the Global Cannabis Market. Yossi Bornstein, CEO of Shizim Ltd, and Chairman of Cann10 International, stated \"Blue Diamond Ventures offered us a unique combination of experience and knowledge for the North American market”. The acquisition of shares in Cann10 North America, is in addition progress made on the other two main areas of focus by BLDV, Building and Leasing of facilities through the Innovat...